Azelis Delivers 11% Free Cash Flow Growth in H1 2025
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250730152197/en/
Highlights H1 2025
-
Revenue of
EUR 2.2bn in H1 2025, representing year-on-year increase of 0.6% (+3.3% on a constant currency basis), with 1.2% organic revenue growth and 2.2% revenue growth contribution from acquisitions offsetting the negative F/X impact during the period. -
Gross profit of
EUR 515m resulting in gross profit margin of 23.9%. The 68 bp gross margin contraction reflects the mix effect from higher growth contribution fromIndustrial Chemicals and the Group's less mature businesses. -
Adjusted EBITA of
EUR 234m results in adjusted EBITA margin of 10.9%, and conversion margin of 45.5%. The EBITA and conversion margins do not yet reflect the full benefit of cost savings measures announced at the beginning of Q2. -
Net profit of
EUR 85m represents a decline of 14.6% over the prior year, driven by the lower operating profit. -
Free cash flow increased by 10.8% over the prior year to
EUR 151m despite the lower EBITDA. Cash conversion expanded by more than 10 percentage points to 63.8% underscoring the resilient, cash-generative nature of the business model. -
Two acquisitions were completed in H1 2025, and a third was announced shortly after the close of the period. The three companies had combined annual revenue of over
EUR 100m in 2024. - The Group is focused on managing its costs whilst uncertainty persists in the near-term, whilst continuing to execute on its medium-term strategy to capture the benefits of an attractive industry.
Comment from
Despite the impact of the growing trade and geopolitical uncertainty around the world, we remain confident that we have the right strategy to ensure that we capture the opportunities created by the volatility in the industry and emerge stronger than before.”
View source version on businesswire.com: https://www.businesswire.com/news/home/20250730152197/en/
Azelis Investor Relations
T: +32 3 613 01 27
E: investor-relations@azelis.com
Source: